Mechanisms for oxidative stress in diabetic cardiovascular disease

被引:129
作者
Pennathur, Subramaniam [1 ]
Heinecke, Jay W.
机构
[1] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
[2] Univ Washington, Dept Med, Seattle, WA 98195 USA
关键词
D O I
10.1089/ars.2007.1595
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity, metabolic syndrome, and diabetes are increasingly prevalent in Western society, and they markedly increase the risk for atherosclerotic vascular disease, the major cause of death in diabetics. Although recent evidence suggests a causal role for oxidative stress in insulin resistance, diabetes, and atherosclerosis, there is considerable controversy regarding its nature, magnitude, and underlying mechanisms. Glucose promotes glycoxidation reactions in vitro, and products of glycoxidation and lipoxidation are elevated in plasma and tissue from humans suffering from diabetes, but the exact relationships between hyperglycemia and oxidative stress are poorly understood. This review focuses on molecular mechanisms of increased oxidative stress in diabetes, the relationship of oxidant production to hyperglycemia, and the potential interaction of reactive carbonyls and lipids in oxidant generation. Using highly sensitive and specific gas chromatography-mass spectrometry, molecular signatures of specific oxidation pathways were identified in tissues of diabetic humans and animals. These studies support the hypothesis that unique reactive intermediates generated in localized microenvironments of vulnerable tissues promote diabetic damage. Therapies interrupting these reactive pathways in vascular tissue might help prevent cardiovascular disease in this high-risk population.
引用
收藏
页码:955 / 969
页数:15
相关论文
共 154 条
[51]   3-chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima [J].
Hazen, SL ;
Heinecke, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09) :2075-2081
[52]   Clinical trials of vitamin E in coronary artery disease: Is it time to reconsider the low-density lipoprotein oxidation hypothesis? [J].
Jay W. Heinecke .
Current Atherosclerosis Reports, 2003, 5 (2) :83-87
[53]   IRON AND COPPER PROMOTE MODIFICATION OF LOW-DENSITY LIPOPROTEIN BY HUMAN ARTERIAL SMOOTH-MUSCLE CELLS IN CULTURE [J].
HEINECKE, JW ;
ROSEN, H ;
CHAIT, A .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (05) :1890-1894
[54]  
Heinecke JW, 2003, AM J CARDIOL, V91, p12A
[55]   Oxidized amino acids: Culprits in human atherosclerosis and indicators of oxidative stress [J].
Heinecke, JW .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (11) :1090-1101
[56]   Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis [J].
Heinecke, JW .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (08) :1261-1264
[57]   Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical reactive aldehydes, hypochlorous acid and molecular chlorine [J].
Heinecke, JW .
BIOFACTORS, 1997, 6 (02) :145-155
[58]   Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall [J].
Heinecke, JW .
FASEB JOURNAL, 1999, 13 (10) :1113-1120
[59]   Reactive oxygen species have a causal role in multiple forms of insulin resistance [J].
Houstis, N ;
Rosen, ED ;
Lander, ES .
NATURE, 2006, 440 (7086) :944-948
[60]   The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women - 20 years of follow-up [J].
Hu, FB ;
Stampfer, MJ ;
Solomon, CG ;
Liu, SM ;
Willett, WC ;
Speizer, FE ;
Nathan, DM ;
Manson, JE .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (14) :1717-1723